PTCA with drug-coated balloons is associated with immediate decrease of coronary flow reserve

Mabelle Young1, Florim Cuculi, Paul Erne

  • 1Department of Cardiology, Luzerner Kantonsspital, Luzern, Switzerland.

Insights

Drug-coated balloons (DCB) temporarily decrease coronary flow reserve (CFR) immediately after use, but this effect resolves within 10 minutes. Further research is needed to understand the long-term implications of this acute CFR drop.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research

Background:

  • Drug-coated balloons (DCB) are increasingly utilized in interventional cardiology procedures.
  • The acute impact of DCB on coronary flow reserve (CFR) has not been previously documented.

Purpose of the Study:

  • To investigate the immediate effects of DCB on coronary flow reserve (CFR).
  • To assess the temporal changes in CFR following DCB application.

Main Methods:

  • Coronary flow reserve (CFR) was measured using the FloWire in patients undergoing procedures for in-stent restenosis or with clopidogrel contraindications.
  • CFR was assessed before and after conventional balloon angioplasty, and subsequently after the use of a paclitaxel-eluting DCB (In.Pact).
  • In a subset of patients, CFR was serially measured up to 10 minutes post-DCB implantation.

Main Results:

  • A total of 32 lesions in 30 patients were analyzed.
  • Conventional balloon angioplasty did not significantly alter CFR (P = 0.95).
  • The use of In.Pact DCB resulted in a significant acute decrease in CFR (1.59 ± 0.49 to 1.22 ± 0.28, P < 0.0001).
  • CFR demonstrated a statistically significant improvement within 10 minutes post-DCB in a subgroup of patients (P = 0.01).
  • Subsequent coronary stent implantation rapidly restored CFR (P = 0.0004).

Conclusions:

  • A novel observation of an acute, transient decrease in CFR following DCB use is reported.
  • The observed reduction in CFR is temporary, with spontaneous recovery occurring around 10 minutes.
  • The underlying pathophysiological mechanisms require further investigation, alongside studies on the long-term consequences of this acute effect.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...